A placebo-controlled trial of adjunctive quetiapine for refractory PTSD.

Trial Profile

A placebo-controlled trial of adjunctive quetiapine for refractory PTSD.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned number of patients changed from 114 to 118 as reported by ClinicalTrials.gov.
    • 01 Apr 2009 Planned end date changed from 1 Nov 2008 to 1 May 2009 as reported by ClinicalTrials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top